基蛋生物 (603387)
Getein Biotech, Inc.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 50715.35
- Circulating A-Shares(W): 50715.35
- Earnings Per Share(RMB): 0.3200
- Net Assets Per Share(RMB): 5.3062
- Operating Revenue(W RMB): 75768.92
- Total Profit(W RMB): 16317.53
- **Net Profit Attributable to Parent(W RMB) **: 16054.38
- Net Profit Growth Rate(%): -8.48
- Weighted Return on Equity(%): 6.0000
- Operating Cash Flow Per Share(RMB): 0.4640
- Undistributed Profit Per Share(RMB): 3.3303
- Capital Reserve Per Share(RMB): 0.4656
2. Main Business
The main business covers:
- Research, development, production, and sales of in vitro diagnostic products.
3. Company Basic Information
- Company Name: Getein Biotech, Inc.
- Listing Date: 2017-07-17
- Industry: Pharmaceutical Manufacturing
- Address: No. 9 Bofu Road, Yanjiang Industrial Development Zone, Luhe District, Nanjing City, Jiangsu Province
- Website: https://www.getein.com.cn/
- Company Profile: The issuer was established as a joint stock company through the overall change of Getein Limited. Getein Limited converted its audited net assets as of September 30, 2014, into the company's share capital of 99 million shares at RMB 1 per share, with the remaining portion of the audited net assets recorded into the company's capital reserve. The shareholding ratios of all shareholders remained unchanged before and after the issuer's transformation into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Nanjing Aiji Business Information Consulting Co., Ltd. | General Legal Person | 1688.12 | 3.33 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1287.25 | 2.54 |
5. Concept Sectors
- Venture Capital Concept
- Helicobacter Pylori Concept
- Hepatitis Concept
- Pet Economy
- Margin Trading & Securities Lending
Remarks
- Data update date: 2025-11-01
- Data source: Public Market Information